A Study to Investigate the Safety and Efficacy of mRNA-1403 in Participants ≥18 Years of Age for the Prevention of Acute Gastroenteritis

Last updated:
2026-07-18
Language and content disclaimer

The content and search results on this site are collected from or provided by third parties. As such some of the information may only be available in the language originally submitted by the sponsor of the trial. Learn more about the information on the search portal.

Linking to Non-Government of Canada Websites

Links to websites not under the control of the Government of Canada, including those to our social media accounts, and to clinical trial records in international registries are provided solely for the convenience of our website visitors. We are not responsible for the accuracy, currency or reliability of the content of such websites. The Government of Canada does not offer any guarantee in that regard and is not responsible for the information found through these links, nor does it endorse the sites and their content.

Visitors should also be aware that information offered by non-Government of Canada sites to which this website links is not subject to the Privacy Act or the Official Languages Act and may not be accessible to persons with disabilities. The information offered may be available only in the language(s) used by the sites in question. With respect to privacy, visitors should research the privacy policies of these non-government websites before providing personal information.

View trial details

Overview

Official protocol title:

A PHASE 3, RANDOMIZED, OBSERVER-BLINDED PLACEBO-CONTROLLED STUDY TO EVALUATE THE SAFETY AND EFFICACY OF MRNA-1403, A MULTIVALENT CANDIDATE VACCINE TO PREVENT NOROVIRUS ACUTE GASTROENTERITIS IN ADULTS >=18 YEARS OF AGE

Intervention/treatment:
MRNA-1403
Medical condition:
VIRAL GASTROENTERITIS
Protocol code:
MRNA-1403-P301
Control number:
289885
Status:
Active, not recruiting
Approved:
September 26, 2024
Trial phase:
Phase 3
For more information:
ClinicalTrials.gov - NCT06592794
This is an external link. The information is not authorized by the Government of Canada.

Eligibility

Sex: ALL
Age
18 Years and older
Accepts healthy volunteers: Yes

Contacts and locations

Contact
Sponsor
MODERNATX, INC.

Locations

Apex Trials
Guelph
ACTIVE_NOT_RECRUITING
Bluewater Clinical Research Group, Inc
Sarnia
ACTIVE_NOT_RECRUITING
CARe Clinic
Calgary
ACTIVE_NOT_RECRUITING
CARe Clinic Red Deer
Red Deer
ACTIVE_NOT_RECRUITING
Centre de Recherche Saint-Louis
Québec
ACTIVE_NOT_RECRUITING
Centricity Research Mirabel
Mirabel
ACTIVE_NOT_RECRUITING
Centricity Research Pointe-Claire
Pointe-Claire
ACTIVE_NOT_RECRUITING
Centricity Research Quebec City
Lévis
ACTIVE_NOT_RECRUITING
Centricity Research Toronto LMC
Toronto
ACTIVE_NOT_RECRUITING
Clinique Spécialisée en Allergie de la Capitale
Québec
ACTIVE_NOT_RECRUITING
Colchester Research Group
Truro
ACTIVE_NOT_RECRUITING
Diex Recherche Trois-Rivières
Trois-Rivières
ACTIVE_NOT_RECRUITING
Diex Research Sherbrooke Inc
Sherbrooke
ACTIVE_NOT_RECRUITING
Intermed Groupe Sante
Chicoutimi
ACTIVE_NOT_RECRUITING
Isaak Walton Killam Health Centre
Halifax
ACTIVE_NOT_RECRUITING
Medicor Research Inc.
Greater Sudbury
ACTIVE_NOT_RECRUITING
Milestone Research Inc.
London
ACTIVE_NOT_RECRUITING
Okanagan Clinical Trials
Kelowna
ACTIVE_NOT_RECRUITING
Richmond Clinical Trials
Richmond
ACTIVE_NOT_RECRUITING
Did you find what you were looking for?